Medical, MLR, regulatory, legal, or compliance teams
You already manage approved claims, substantiation files, review dates, and owners. The hard part is knowing which items deserve a second look between normal review cycles.
Evidence-sensitive claim support intelligence
Know which claims may need another look — and why.
NextConsensus monitors the evidence behind claims already in use and identifies changes that may warrant qualified re-review. Each assessment traces what changed, which claim it may affect, and why.
Check your claims See a sample assessment
Your existing systems keep approval, document control, and final action. NC shows which claims may need reviewer attention and why.
Who should recognize this
You are not looking for more evidence. You are trying to protect prior claims as evidence changes.
The visitor who understands NC fastest already owns claim language, evidence review, reviewer capacity, or the operational record behind approved statements. They know evidence changes. They need to know which relied-on claims now deserve scarce review time.
Market access, HEOR, commercial strategy, or payer teams
You care when new evidence changes the support for a value, outcomes, access, comparator, or population claim already in circulation.
Digital, AI, knowledge, or evidence operations
You manage reused evidence language across systems and need a traceable way to keep dated claims linked to the source record that still supports them.
The missing object
The claim and its source record need to stay linked.
Claims systems store approved language. Evidence tools help find and summarize sources. Intelligence teams notice external movement. NC connects those pieces into a maintained source record and a claim-specific review packet: what the claim means, what it depends on, what changed, and what decision a reviewer needs to make.
Claim identity
The exact approved wording, including qualifier, population, comparator, endpoint, audience, and use context.
Evidence dependency
The sources and assumptions the claim depended on at the last defensible review.
Evidence movement
What changed since then: study, label, guideline, safety item, source removal, comparator movement, or wording drift.
Decision to make
The specific decision a qualified owner can record: preserve, clarify, narrow, caveat, escalate, suspend, retire, or defer.
Disposition history
What the customer decided, what remained uncertain, and what should cause the claim to be checked again.
The first mode is claim maintenance: can we still stand behind what we already say? Adjacent opportunity detection comes later. The pilot starts with approved claims already in use.
Not another feed
Reviewer time is the scarce resource.
Most teams do not need another stream of papers, abstracts, notices, or summaries. They need a ranked list of the approved claims most likely to deserve review now, with enough source detail for a qualified reviewer to decide what to do.
NC is not trying to own
Finding every possible claim your organization could make.
Replacing MLR, legal, regulatory, medical, or clinical judgment.
Running downstream approval workflow, document control, or change management.
Owning valuation, capital allocation, or portfolio decisions.
Review cycles are too blunt for evidence that changes between them.
Every approved claim carries a prior evidence judgment. Months later, new studies, labels, guidelines, safety updates, and competitor evidence can make old wording weaker, stronger, narrower, or less precise than the record allows. NC turns that movement into a ranked re-review list instead of another watch feed.
Evidence moves. Review cycles hold. The gap is where stale, overbroad, or underused approved claims quietly accumulate.
How claims slip
Claims lose their caveats one word at a time.
The same approved statement, reused across assets and field materials, can lose its population, endpoint, timing, or source limit. What remains can look more current than the record allows.
Coverage “restricted to this subgroup” “restriction still current”
Pathway “after failure of standard therapy” “standard pathway step”
MLR claim “observed in trial population” “demonstrated broadly”
AI validation “validated for this deployment population” “validated”
Capacity “screening starts at this threshold” “capacity plan unchanged”
Claim-specific review packet — sample output
Support, objections, reliance context, and uncertainty — traced to the source record.
The first product
Start with the seven claims worth attention, not the 94 new papers.
Upload the approved claims your team already uses. NC returns a ranked re-review list: the few claims that may deserve attention now, the reason each one appeared, and the packet for each flagged claim. Each review packet preserves the source record, rationale, use context, explicit limits, and the decision your team records.
- Exact wording
The approved claim as your team uses it now, with the qualifier, population, comparator, and endpoint kept visible.
- What changed
The new study, label update, guideline, safety item, source removal, or wording change that pushed this claim onto the ranked re-review list.
- What still holds
The strongest remaining support and the boundaries it still depends on.
- What may need a caveat
Where the wording may be too broad, too stale, or missing a qualification reviewers would expect to see.
- The decision to make
The specific decision a qualified owner can record: preserve, clarify, narrow, escalate, or retire.
Delivered as a ranked re-review list with source-traced claim-specific review packets. Every item includes source references, a review-date stamp, explicit limits, and a reproducible evidence basis.
The risk
Evidence changes before claim review cycles do.
Illustrative review scenarios:
"We built our formulary argument on a readout that got walked back at the advisory committee. Nobody knew whether it deserved re-review for eighteen months."
"Our competitive positioning assumed their label was narrower. It wasn't anymore by the time we presented at the P&T."
"The pathway reflects the guideline from two cycles ago. Between updates, nobody checked whether the evidence had shifted."
"We assumed the safety narrative was stable. Three abstracts and a label update later, the payer argument was already broken."
NextConsensus connects evidence movement to the affected claim, source trail, known use context, and reviewer question so teams know which items deserve scarce reviewer time.
What compounds
Every review leaves a better institutional memory.
Each review records the approved claim, the source record it relied on, what changed, the decision to make, the customer's decision, and the conditions for checking again. Over time, that history makes future re-review faster and more defensible without turning NC into the final authority.
BL-2026-014 RE-REVIEW CANDIDATE sha256:a3f1…c8e2
APPROVED CLAIM
Effective in high-risk patients with confirmed cardiovascular benefit
strikethrough weakened underline strengthened
WHY REVIEW NOW Review reason found
CLAIM BOUNDARIES population · endpoint · source
KNOWN USE population qualifier removed
CUSTOMER CONTEXT customer-owned assumptions
SOURCES (4)
FDA label Advisory committee transcript Citation removed Mar 2026 Guideline — pending update
RE-REVIEW · same claim, later interval · Illustrative
state Review candidate → Support narrowed
reliance gap population qualifier removed → cardiovascular benefit contested
sources 4 → 3 (1 citation retracted)
hash a3f1…c8e2 → 7b2d…f4a1
Process
Send the claims. NC returns the review list.
PRESERVE support still holds CAVEAT scope changed ESCALATE review needed RETIRE support no longer fits
Evidence state is the input. The handoff is a claim-specific review packet and a place for your team to record its decision.
1
Send the claims you already use
Start with approved claim text, where it appears, the review owner, and the sources your team cares about.
2
NC checks what changed
NC compares those claims against new evidence, source changes, label or guideline movement, and wording drift.
3
Review the ranked list
You see which claims deserve attention, why each one appeared, and the question a qualified reviewer should answer.
4
Record the decision
Your team decides what to do. NC preserves the source trail, rationale, limits, and decision history.
Public examples run on Refract, the open-source claim-history engine. Private packets include the sources your team wants included, use context, and review boundary.
Pilot metrics
A practical way to test value.
Timeliness, review yield, and reviewer efficiency.
A pilot should test whether the ranked list reaches reviewers while action is still useful, whether a meaningful share deserves expert consideration, and whether teams spend less time on broad searching, manual matching, and duplicate documentation.
Fit
This is probably for you if four things are true.
Your team has approved claims or medical narratives that keep getting reused.
Those claims depend on changing external evidence: labels, guidelines, studies, safety updates, or competitor evidence.
Re-review capacity is limited, so another watch feed is not enough.
Qualified reviewers must keep final authority over wording, approval, materiality, and action.
Pilot setup
Start narrow enough to measure.
The first deployment should not be a vague monitoring program. It should be a focused review system with explicit claims, sources, event types, human verification, coverage limits, and pilot outcomes.
A defined set of material, evidence-sensitive claims.
A named set of scientific, regulatory, guideline, and competitive sources.
Explicit event types: new study, label update, guideline shift, safety item, source removal, comparator movement, or wording drift.
Human-verified source records with transparent limits.
Measurable outcomes: fewer low-value searches, better review yield, clearer provenance, and more expert time directed to the claims that need it.
Authority boundary
NC identifies what may need review. Qualified teams decide what to do.
NextConsensus monitors, matches, compares, prioritizes, explains, and produces claim-specific review packets. Qualified reviewers decide whether to preserve, clarify, narrow, caveat, escalate, suspend, retire, or defer an approved claim.
Method basis
The method basis is evidence updating, not decision substitution.
These works frame the operating boundary: evidence changes unevenly, formal review can lag, and final institutional decisions require context NC does not own.
- The answer is 17 years, what is the question: understanding time lags in translational research
Background on the gap between evidence production and institutional uptake; useful as caution, not as a fixed timing claim.
- Living systematic review: 1. Introduction-the why, what, when, and how
Frames evidence synthesis as an updating problem, not a one-time search problem.
- GRADE Evidence to Decision frameworks: a systematic and transparent approach to making well informed healthcare choices
Shows why evidence assessment and final decisions should be structured separately.
Ready to see which approved claims may warrant re-review?
Send 100–300 approved claims, where they appear, the sources you care about, and the review owner. We confirm whether a ranked re-review list is measurable, then show which claims may deserve attention and why.
Send claim text, intended use, audience, population, source list, and review window. We reply with fit confirmation before any work begins.